FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Proteonomix

Sort
E.g., 2013-05-18
E.g., 2013-05-18
Enter a comma separated list of user names.

Proteonomix (PROT.OB) a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, is pleased to provide an update on the Company's addition to its Board of Directors. Proteonomix, Inc. is pleased to announce that Ian McNiece has been appointed to the Proteonomix Board of Directors.

The China Fund, Inc.(NYSE:CHN) confirmed the amount of distributions of $2.2742 per share. The capital gain portion of the distributions is comprised of long-term capital gains at $1.8996 per share. The net investment income portion of the distribution is $0.3746 per share.

Proteonomix, Inc. (PROT.OB) is pleased to announce that Ian McNiece has been appointed to the Proteonomix Board of Directors. Dr. McNiece, has served as Vice-President for Scientific Development and Chief Scientific Officer since November 11, 2009.

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, reported that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii.

Proteonomix, Inc. (PROT.OB) recently reported further developments with its Joint Venture Company, XGEN Medical LLC (”XGen”) towards implementing operations in the United Arab Emirates.

Proteonomix, Inc. (OTC.BB:PROT) reported that Proteonomix has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

RadioShack Corp. (NYSE: RSH) celebrated its 75th anniversary of listing on the New York Stock Exchange.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Stock-PR Reporting

FREE Daily Stock Alerts From Stock-PR.com

________________________________________

___

Proteonomix, Inc. (PROT.OB)

PROT announced that it has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

Proteonomix, Inc., (OTCBB:PROT.OB) has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

International Business Machines Corp. (NYSE:IBM) and Universiti Brunei Darussalam (UBD) previously announced an agreement to collaborate on climate modeling research that will investigate the impact of climate change on flood forecasting, crop yields, renewable energy and the health of rainforests in the region.

Pages

ADVERTISE WITH US